Device Tax Repeal Faces Tough Slog Despite Senate Vote

Law360, New York (March 26, 2013, 7:23 PM EDT) -- Medical device makers shouldn't get too excited about last week's symbolic U.S. Senate vote to scrap a controversial health reform tax on their sales, according to experts who say repeal must confront a $30 billion price tag and the prospect that hospitals, drug firms and health insurers might demand similar reprieves.

The device industry’s anti-tax campaign has been undeniably impressive; at least 40 corporations and trade groups have prodded lawmakers to ax the 2.3 percent levy, disclosure reports show. But a nonbinding vote — even a...
To view the full article, register now.